Upgrade to SI Premium - Free Trial

Celanese Corporation Reports First Quarter Earnings

May 8, 2024 4:15 PM

DALLAS--(BUSINESS WIRE)-- Celanese Corporation (NYSE: CE), a global chemical and specialty materials company, today reported first quarter 2024 U.S. GAAP diluted earnings per share of $1.10 and adjusted earnings per share of $2.08. The Company generated net sales of $2.6 billion in the quarter, an increase of 2 percent from the prior quarter, reflecting a sequential increase in volume of 2 percent and neutral pricing. Celanese continued to execute against controllable actions in a demand environment that is stabilizing but has not yet returned to normalized levels. As a result, the Company largely offset the sequential impacts of first quarter seasonality as well as significantly higher expenses associated with the completion of planned turnarounds. Celanese reported first quarter operating profit of $210 million, adjusted EBIT of $407 million, and operating EBITDA of $583 million at margins of 8, 16, and 22 percent, respectively.

The difference between U.S. GAAP diluted earnings per share and adjusted earnings per share in the first quarter was primarily due to Certain Items totaling $97 million.1

"Our first quarter results demonstrate our ability to execute in a commercial environment that has stabilized but still shows limited signs of meaningful recovery," said Lori Ryerkerk, chair and chief executive officer. "We saw the realization of financial benefits from actions that were completed last year, particularly within the former M&M portfolio, and we continue to put in place further initiatives to enhance the earnings power of Celanese. I thank our teams for their dedication in executing our plan, allowing us to exceed our previous earnings expectations for the quarter."

_____________________________

1 Mainly driven by shutdown-related costs and M&A-related costs

First Quarter 2024 Financial Highlights:

Three Months Ended

March 31,
2024

December 31,
2023

March 31,
2023

(unaudited)

(In $ millions, except per share data)

Net Sales

Engineered Materials

1,378

1,406

1,630

Acetyl Chain

1,261

1,181

1,250

Intersegment Eliminations

(28

)

(18

)

(27

)

Total

2,611

2,569

2,853

Operating Profit (Loss)

Engineered Materials

89

122

112

Acetyl Chain

254

264

278

Other Activities

(133

)

(127

)

(139

)

Total

210

259

251

Net Earnings (Loss)

124

701

93

Adjusted EBIT(1)

Engineered Materials

201

199

215

Acetyl Chain

296

300

316

Other Activities

(90

)

(65

)

(107

)

Total

407

434

424

Equity Earnings and Dividend Income, Other Income (Expense)

Engineered Materials

50

45

10

Acetyl Chain

36

33

34

Operating EBITDA(1)

583

608

596

Diluted EPS - continuing operations

$

1.10

$

6.43

$

0.86

Diluted EPS - total

$

1.10

$

6.37

$

0.83

Adjusted EPS(1)

$

2.08

$

2.24

$

2.01

Net cash provided by (used in) investing activities

(151

)

(168

)

(178

)

Net cash provided by (used in) financing activities

(259

)

(240

)

(69

)

Net cash provided by (used in) operating activities

101

830

(96

)

Free cash flow(1)

(40

)

702

(261

)

____________________________

(1)

See "Non-US GAAP Financial Measures" below.

Recent Highlights:

First Quarter Business Segment Overview

Acetyl Chain

The Acetyl Chain delivered first quarter net sales of $1.3 billion, a 7 percent increase from the prior quarter. Volume increased by 5 percent sequentially due to a modest increase in Asia demand and seasonal recovery in the Americas and Europe. First quarter pricing across the Acetyl Chain increased by 1 percent sequentially. In response to challenging commercial dynamics with acetic acid in China, the business exercised its unique optionality within its integrated value chain to capture margin through downstream derivatives such as emulsions and RDP. The Acetyl Chain delivered first quarter operating profit of $254 million, adjusted EBIT of $296 million, and operating EBITDA of $353 million at margins of 20, 23, and 28 percent, respectively. The business completed a planned seven week methanol turnaround on time and under budget. Additionally, the new acetic acid production unit at Clear Lake supported the business to drive incremental earnings across its network and partially offset the sequential increase in methanol turnaround expenses. The Acetyl Chain continued to take steps to support its foundational earnings by increasing downstream optionality through the successful addition of capacity in VAE and RDP.

Engineered Materials

Engineered Materials reported first quarter net sales of $1.4 billion, representing a sequential decrease of 2 percent. Net sales reflected a sequential volume decrease of 1 percent and a sequential pricing decrease of 1 percent. Volume was similar to the previous quarter with slight improvements in both automotive and distribution volumes partially offset by seasonal declines in medical implants. Engineered Materials delivered first quarter operating profit of $89 million, adjusted EBIT of $201 million, and operating EBITDA of $303 million, at margins of 6, 15, and 22 percent, respectively. The sequential earnings performance was mainly driven by realization of lower raw material costs flowing through inventory as well as sales mix improvements. Both dynamics were especially prominent in the nylon business, which delivered a $26 million sequential increase in gross profit contribution and the highest quarterly contribution from the former M&M product portfolio since the completion of the acquisition. Engineered Materials implemented further value enhancing initiatives to continue driving margin expansion. Among these were the closure of nylon 66 polymerization in Uentrop, Germany, the integration of the former M&M business onto the upgraded SAP S/4HANA ERP system, and the announcement of plans to cease all operations at the specialty compounding site in Mechelen, Belgium which was acquired as part of the M&M acquisition.

Cash Flow and Tax

Celanese reported first quarter operating cash flow of $101 million and free cash flow of $(40) million, representing increases of $197 million and $221 million, respectively, when compared to the same period of last year. First quarter results included a sequential increase in working capital from typical seasonality, net cash interest expense of $204 million due to timing of coupon payments, and cash capital expenditures of $137 million driven by project completion timing. Celanese returned $77 million in cash to shareholders via dividends in the quarter.

The effective U.S. GAAP income tax rate was 21 percent for the first quarter compared to 21 percent for the same quarter in 2023. The U.S. GAAP effective rate for the current year was unfavorably impacted by the tax effect of debt restructuring transactions, and the U.S. GAAP rate for the prior period was unfavorably impacted by increases in valuation allowances on U.S. foreign tax credit carryforwards due to revised forecasts of foreign sourced income and expenses during the carryforward period that did not re-occur in the current period. The effective tax rate for adjusted earnings was 9 percent based on expected jurisdictional earnings mix for the full year and consideration of other non-recurring U.S. GAAP items.

Outlook

"Given the current demand environment and muted seasonal commercial lift, our focus will remain on what we can control to sustainably lift the earnings of Celanese," said Lori Ryerkerk. "Along with further improvement in the profitability of our acquired product portfolio, we expect benefits from our Clear Lake expansion, Uentrop closure, and SAP S/4HANA ERP integration to contribute in the second quarter and accelerate across the year. Because of these foundational value creation initiatives, I am confident we will deliver a ramp in earnings performance in the second quarter and into the second half of the year."

Based on the timing of major value creation projects and reflective of the current commercial environment, the Company anticipates second quarter adjusted earnings per share of $2.60 to $3.00, inclusive of approximately $0.30 per share of M&M transaction amortization.

Reconciliations of forecasted non-GAAP measures such as adjusted earnings per share, adjusted EBIT or free cash flow to the equivalent U.S. GAAP measures (diluted earnings per share, net earnings (loss) attributable to Celanese Corporation and net cash provided by (used in) operations, respectively), are not available without unreasonable efforts because a forecast of Certain Items, such as mark-to-market pension gains/losses, and other items is not practical. For more information, see "Non-GAAP Financial Measures" below.

The Company's prepared remarks related to the first quarter will be posted on its website at investors.celanese.com under Financial Information/Financial Document Library on May 8, 2024. Information about Non-US GAAP measures is included in a Non-US GAAP Financial Measures and Supplemental Information document posted on our investor relations website under Financial Information/Non-GAAP Financial Measures. See also "Non-GAAP Financial Measures" below.

Celanese Corporation is a global leader in chemistry, producing specialty material solutions used across most major industries and consumer applications. Our businesses use our chemistry, technology and commercial expertise to create value for our customers, employees and shareholders. We support sustainability by responsibly managing the materials we create and growing our portfolio of sustainable products to meet customer and societal demand. We strive to make a positive impact in our communities and to foster inclusivity across our teams. Celanese Corporation is a Fortune 500 company that employs approximately 12,400 employees worldwide with 2023 net sales of $10.9 billion.

Forward-Looking Statements

This release may contain "forward-looking statements," which include information concerning the Company's plans, objectives, goals, strategies, future revenues, cash flow, financial performance, synergies, capital expenditures, financing needs and other information that is not historical information. All forward-looking statements are based upon current expectations and beliefs and various assumptions. There can be no assurance that the Company will realize these expectations or that these beliefs will prove correct. There are a number of risks and uncertainties that could cause actual results to differ materially from the results expressed or implied in the forward-looking statements contained in this release. These risks and uncertainties include, among other things: changes in general economic, business, political and regulatory conditions in the countries or regions in which we operate; the length and depth of product and industry business cycles, particularly in the automotive, electrical, textiles, electronics and construction industries; volatility or changes in the price and availability of raw materials and energy, particularly changes in the demand for, supply of, and market prices of ethylene, methanol, natural gas, wood pulp and fuel oil and the prices for electricity and other energy sources; the ability to pass increases in raw material prices, logistics costs and other costs on to customers or otherwise improve margins through price increases; the possibility that we will not be able to timely or effectively continue to integrate the Mobility & Materials business (the "M&M Business") we acquired from DuPont de Nemours, Inc. (the "M&M Acquisition") in order to realize the anticipated benefits of the M&M Acquisition, including synergies and growth opportunities, whether as a result of difficulties arising from the operation of the M&M Business or other unanticipated delays, costs, inefficiencies or liabilities; increased commercial, legal or regulatory complexity of entering into, or expanding our exposure to, certain end markets and geographies; risks in the global economy and equity and credit markets and their potential impact on our ability to pay down debt in the future and/or refinance at suitable rates, in a timely manner, or at all; risks and costs associated with increased leverage from the M&M Acquisition, including increased interest expense and potential reduction of business and strategic flexibility; the ability to maintain plant utilization rates and to implement planned capacity additions, expansions and maintenance; the ability to reduce or maintain current levels of production costs and to improve productivity by implementing technological improvements to existing plants; increased price competition and the introduction of competing products by other companies; the ability to identify desirable potential acquisition or divestiture opportunities and to complete such transactions, including obtaining regulatory approvals, consistent with the Company's strategy; market acceptance of our products and technology; compliance and other costs and potential disruption or interruption of production or operations due to accidents, interruptions in sources of raw materials, transportation, logistics or supply chain disruptions, cybersecurity incidents, terrorism or political unrest, public health crises (including, but not limited to, the COVID-19 pandemic), or other unforeseen events or delays in construction or operation of facilities, including as a result of geopolitical conditions, the direct or indirect consequences of acts of war or conflict (such as the Russia-Ukraine conflict or the Israel-Hamas conflict) or terrorist incidents or as a result of weather, natural disasters, or other crises; the ability to obtain governmental approvals and to construct facilities on terms and schedules acceptable to the Company; changes in applicable tariffs, duties and trade agreements, tax rates or legislation throughout the world including, but not limited to, adjustments, changes in estimates or interpretations or the resolution of tax examinations or audits that may impact recorded or future tax impacts and potential regulatory and legislative tax developments in the United States and other jurisdictions; changes in the degree of intellectual property and other legal protection afforded to our products or technologies, or the theft of such intellectual property; potential liability for remedial actions and increased costs under existing or future environmental, health and safety regulations, including those relating to climate change or other sustainability matters; potential liability resulting from pending or future claims or litigation, including investigations or enforcement actions, or from changes in the laws, regulations or policies of governments or other governmental activities in the countries in which we operate; changes in currency exchange rates and interest rates; our level of indebtedness, which could diminish our ability to raise additional capital to fund operations or limit our ability to react to changes in the economy or the chemicals industry; tax rates and changes thereto; and various other factors discussed from time to time in the Company's filings with the Securities and Exchange Commission.

Any forward-looking statement speaks only as of the date on which it is made, and the Company undertakes no obligation to update any forward-looking statements to reflect events or circumstances after the date on which it is made or to reflect the occurrence of anticipated or unanticipated events or circumstances.

Non-GAAP Financial Measures

Presentation

This document presents the Company's two business segments, Engineered Materials and the Acetyl Chain.

Use of Non-US GAAP Financial Information

This release uses the following Non-US GAAP measures: adjusted EBIT, adjusted EBIT margin, operating EBITDA, operating EBITDA margin, adjusted earnings per share and free cash flow. These measures are not recognized in accordance with US GAAP and should not be viewed as an alternative to US GAAP measures of performance or liquidity. The most directly comparable financial measure presented in accordance with US GAAP in our consolidated financial statements for adjusted EBIT and operating EBITDA is net earnings (loss) attributable to Celanese Corporation; for adjusted EBIT margin is operating margin; for operating EBITDA margin is operating margin; for adjusted earnings per share is earnings (loss) from continuing operations attributable to Celanese Corporation per common share-diluted; and for free cash flow is net cash provided by (used in) operations.

Definitions of Non-US GAAP Financial Measures

Reconciliation of Non-US GAAP Financial Measures

Reconciliations of the Non-US GAAP financial measures used in this press release to the comparable US GAAP financial measure, together with information about the purposes and uses of Non-US GAAP financial measures, are included in our Non-US GAAP Financial Measures and Supplemental Information document filed as an exhibit to our Current Report on Form 8-K filed with the SEC on or about May 8, 2024 and also available on our website at investors.celanese.com under Financial Information/Financial Document Library.

Results Unaudited

The results in this document, together with the adjustments made to present the results on a comparable basis, have not been audited and are based on internal financial data furnished to management. Quarterly results should not be taken as an indication of the results of operations to be reported for any subsequent period or for the full fiscal year.

Supplemental Information

Additional information about our prior period performance is included in our Quarterly Reports on Form 10-Q and in our Non-US GAAP Financial Measures and Supplemental Information document.

Consolidated Statements of Operations - Unaudited

Three Months Ended

March 31,
2024

December 31,
2023

March 31,
2023

(In $ millions, except share and per share data)

Net sales

2,611

2,569

2,853

Cost of sales

(2,057

)

(1,956

)

(2,222

)

Gross profit

554

613

631

Selling, general and administrative expenses

(265

)

(272

)

(285

)

Amortization of intangible assets

(41

)

(40

)

(41

)

Research and development expenses

(34

)

(32

)

(42

)

Other (charges) gains, net

(14

)

(18

)

(23

)

Foreign exchange gain (loss), net

11

11

6

Gain (loss) on disposition of businesses and assets, net

(1

)

(3

)

5

Operating profit (loss)

210

259

251

Equity in net earnings (loss) of affiliates

55

52

15

Non-operating pension and other postretirement employee benefit (expense) income

2

(67

)

1

Interest expense

(169

)

(178

)

(182

)

Interest income

13

12

8

Dividend income - equity investments

34

31

34

Other income (expense), net

12

23

(6

)

Earnings (loss) from continuing operations before tax

157

132

121

Income tax (provision) benefit

(33

)

575

(25

)

Earnings (loss) from continuing operations

124

707

96

Earnings (loss) from operation of discontinued operations

(8

)

(3

)

Income tax (provision) benefit from discontinued operations

2

Earnings (loss) from discontinued operations

(6

)

(3

)

Net earnings (loss)

124

701

93

Net (earnings) loss attributable to noncontrolling interests

(3

)

(3

)

(2

)

Net earnings (loss) attributable to Celanese Corporation

121

698

91

Amounts attributable to Celanese Corporation

Earnings (loss) from continuing operations

121

704

94

Earnings (loss) from discontinued operations

(6

)

(3

)

Net earnings (loss)

121

698

91

Earnings (loss) per common share - basic

Continuing operations

1.11

6.46

0.87

Discontinued operations

(0.05

)

(0.03

)

Net earnings (loss) - basic

1.11

6.41

0.84

Earnings (loss) per common share - diluted

Continuing operations

1.10

6.43

0.86

Discontinued operations

(0.06

)

(0.03

)

Net earnings (loss) - diluted

1.10

6.37

0.83

Weighted average shares (in millions)

Basic

109.1

109.0

108.6

Diluted

109.5

109.5

109.2

Consolidated Balance Sheets - Unaudited

As of

March 31,

2024

As of

December 31,

2023

(In $ millions)

ASSETS

Current Assets

Cash and cash equivalents

1,483

1,805

Trade receivables - third party and affiliates, net

1,289

1,243

Non-trade receivables, net

536

541

Inventories

2,354

2,357

Other assets

283

272

Total current assets

5,945

6,218

Investments in affiliates

1,238

1,220

Property, plant and equipment, net

5,471

5,584

Operating lease right-of-use assets

396

422

Deferred income taxes

1,618

1,677

Other assets

537

524

Goodwill

6,926

6,977

Intangible assets, net

3,902

3,975

Total assets

26,033

26,597

LIABILITIES AND EQUITY

Current Liabilities

Short-term borrowings and current installments of long-term debt - third party and affiliates

2,439

1,383

Trade payables - third party and affiliates

1,447

1,510

Other liabilities

1,011

1,154

Income taxes payable

28

25

Total current liabilities

4,925

4,072

Long-term debt, net of unamortized deferred financing costs

11,018

12,301

Deferred income taxes

1,016

999

Uncertain tax positions

298

300

Benefit obligations

444

457

Operating lease liabilities

296

325

Other liabilities

505

591

Commitments and Contingencies

Shareholders' Equity

Treasury stock, at cost

(5,488

)

(5,488

)

Additional paid-in capital

383

394

Retained earnings

12,973

12,929

Accumulated other comprehensive income (loss), net

(797

)

(744

)

Total Celanese Corporation shareholders' equity

7,071

7,091

Noncontrolling interests

460

461

Total equity

7,531

7,552

Total liabilities and equity

26,033

26,597

Non-US GAAP Financial Measures and Supplemental Information

May 8, 2024

In this document, the terms the "Company," "we" and "our" refer to Celanese Corporation and its subsidiaries on a consolidated basis.

Purpose

The purpose of this document is to provide information of interest to investors, analysts and other parties including supplemental financial information and reconciliations and other information concerning our use of non-US GAAP financial measures. This document is updated quarterly.

Presentation

This document presents the Company's two business segments, Engineered Materials and the Acetyl Chain.

Use of Non-US GAAP Financial Measures

From time to time, management may publicly disclose certain numerical "non-GAAP financial measures" in the course of our earnings releases, financial presentations, earnings conference calls, investor and analyst meetings and otherwise. For these purposes, the Securities and Exchange Commission ("SEC") defines a "non-GAAP financial measure" as a numerical measure of historical or future financial performance, financial position or cash flows that excludes amounts, or is subject to adjustments that effectively exclude amounts, included in the most directly comparable measure calculated and presented in accordance with US GAAP, and vice versa for measures that include amounts, or are subject to adjustments that effectively include amounts, that are excluded from the most directly comparable US GAAP measure so calculated and presented. For these purposes, "GAAP" refers to generally accepted accounting principles in the United States.

Non-GAAP financial measures disclosed by management are provided as additional information to investors, analysts and other parties because the Company believes them to be important supplemental measures for assessing our financial and operating results and as a means to evaluate our financial condition and period-to-period comparisons. These non-GAAP financial measures should be viewed as supplemental to, and should not be considered in isolation or as alternatives to, net earnings (loss), operating profit (loss), operating margin, cash flow from operating activities (together with cash flow from investing and financing activities), earnings per share or any other US GAAP financial measure. These non-GAAP financial measures should be considered within the context of our complete audited and unaudited financial results for the given period, which are available on the Financial Information/Financial Document Library page of our website, investors.celanese.com. The definition and method of calculation of the non-GAAP financial measures used herein may be different from other companies' methods for calculating measures with the same or similar titles. Investors, analysts and other parties should understand how another company calculates such non-GAAP financial measures before comparing the other company's non-GAAP financial measures to any of our own. These non-GAAP financial measures may not be indicative of the historical operating results of the Company nor are they intended to be predictive or projections of future results.

Pursuant to the requirements of SEC Regulation G, whenever we refer to a non-GAAP financial measure, we will also present in this document, in the presentation itself or on a Form 8-K in connection with the presentation on the Financial Information/Financial Document Library page of our website, investors.celanese.com, to the extent practicable, the most directly comparable financial measure calculated and presented in accordance with GAAP, along with a reconciliation of the differences between the non-GAAP financial measure we reference and such comparable GAAP financial measure.

This document includes definitions and reconciliations of non-GAAP financial measures used from time to time by the Company.

Specific Measures Used

This document provides information about the following non-GAAP measures: adjusted EBIT, adjusted EBIT margin, operating EBITDA, operating EBITDA margin, operating profit (loss) attributable to Celanese Corporation, adjusted earnings per share, net debt, free cash flow and return on invested capital (adjusted). The most directly comparable financial measure presented in accordance with US GAAP in our consolidated financial statements for adjusted EBIT and operating EBITDA is net earnings (loss) attributable to Celanese Corporation; for adjusted EBIT margin and operating EBITDA margin is operating margin; for operating profit (loss) attributable to Celanese Corporation is operating profit (loss); for adjusted earnings per share is earnings (loss) from continuing operations attributable to Celanese Corporation per common share-diluted; for net debt is total debt; for free cash flow is net cash provided by (used in) operations; and for return on invested capital (adjusted) is net earnings (loss) attributable to Celanese Corporation divided by the sum of the average of beginning and end of the year short- and long-term debt and Celanese Corporation shareholders' equity.

Definitions

Note: The income tax expense (benefit) on Certain Items ("Non-GAAP adjustments") is determined using the applicable rates in the taxing jurisdictions in which the Non-GAAP adjustments occurred and includes both current and deferred income tax expense (benefit). The income tax rate used for adjusted earnings per share approximates the midpoint in a range of forecasted tax rates for the year. This range may include certain partial or full-year forecasted tax opportunities and related costs, where applicable, and specifically excludes changes in uncertain tax positions, discrete recognition of GAAP items on a quarterly basis, other pre-tax items adjusted out of our GAAP earnings for adjusted earnings per share purposes and changes in management's assessments regarding the ability to realize deferred tax assets for GAAP. In determining the adjusted earnings per share tax rate, we reflect the impact of foreign tax credits when utilized, or expected to be utilized, absent discrete events impacting the timing of foreign tax credit utilization. We analyze this rate quarterly and adjust it if there is a material change in the range of forecasted tax rates; an updated forecast would not necessarily result in a change to our tax rate used for adjusted earnings per share. The adjusted tax rate is an estimate and may differ from the actual tax rate used for GAAP reporting in any given reporting period. Table 3a summarizes the reconciliation of our estimated GAAP effective tax rate to the adjusted tax rate. The estimated GAAP rate excludes discrete recognition of GAAP items due to our inability to forecast such items. As part of the year-end reconciliation, we will update the reconciliation of the GAAP effective tax rate to the adjusted tax rate for actual results.

Supplemental Information

Supplemental Information we believe to be of interest to investors, analysts and other parties includes the following:

Results Unaudited

The results in this document, together with the adjustments made to present the results on a comparable basis, have not been audited and are based on internal financial data furnished to management. Quarterly results should not be taken as an indication of the results of operations to be reported for any subsequent period or for the full fiscal year.

Table 1

Celanese Adjusted EBIT and Operating EBITDA - Reconciliation of Non-GAAP Measures - Unaudited

Q1 '24

2023

Q4 '23

Q3 '23

Q2 '23

Q1 '23

(In $ millions)

Net earnings (loss) attributable to Celanese Corporation

121

1,960

698

951

220

91

(Earnings) loss from discontinued operations

9

6

1

(1

)

3

Interest income

(13

)

(39

)

(12

)

(12

)

(7

)

(8

)

Interest expense

169

720

178

178

182

182

Refinancing expense

7

7

Income tax provision (benefit)

33

(790

)

(575

)

(236

)

(4

)

25

Certain Items attributable to Celanese Corporation (Table 8)

97

(114

)

139

(438

)

54

131

Adjusted EBIT

407

1,753

434

451

444

424

Depreciation and amortization expense(1)

176

691

174

173

172

172

Operating EBITDA

583

2,444

608

624

616

596

Q1 '24

2023

Q4 '23

Q3 '23

Q2 '23

Q1 '23

(In $ millions)

Engineered Materials

45

15

15

Acetyl Chain

Other Activities(2)

Accelerated depreciation and amortization expense

45

15

15

Depreciation and amortization expense(1)

176

691

174

173

172

172

Total depreciation and amortization expense

221

706

189

173

172

172

______________________________

(1)

Excludes accelerated depreciation and amortization expense as detailed in the table above, which amounts are included in Certain Items above.

(2)

Other Activities includes corporate Selling, general and administrative ("SG&A") expenses, results of captive insurance companies and certain components of net periodic benefit cost (interest cost, expected return on plan assets and net actuarial gains and losses).

Table 2 - Supplemental Segment Data and Reconciliation of Segment Adjusted EBIT and Operating EBITDA - Non-GAAP Measures - Unaudited

Q1 '24

2023

Q4 '23

Q3 '23

Q2 '23

Q1 '23

(In $ millions, except percentages)

Operating Profit (Loss) / Operating Margin

Engineered Materials

89

6.5

%

1,083

17.6

%

122

8.7

%

691

45.2

%

158

10.0

%

112

6.9

%

Acetyl Chain

254

20.1

%

1,109

22.7

%

264

22.4

%

272

22.3

%

295

23.9

%

278

22.2

%

Other Activities(1)

(133

)

(505

)

(127

)

(121

)

(118

)

(139

)

Total

210

8.0

%

1,687

15.4

%

259

10.1

%

842

30.9

%

335

12.0

%

251

8.8

%

Less: Net Earnings (Loss) Attributable to NCI for Engineered Materials

(1

)

(3

)

1

(2

)

(2

)

Less: Net Earnings (Loss) Attributable to NCI for Acetyl Chain

4

7

2

3

2

Operating Profit (Loss) Attributable to Celanese Corporation

207

7.9

%

1,683

15.4

%

256

10.0

%

844

31.0

%

334

11.9

%

249

8.7

%

Operating Profit (Loss) / Operating Margin Attributable to Celanese Corporation

Engineered Materials

90

6.5

%

1,086

17.7

%

121

8.6

%

693

45.4

%

160

10.1

%

112

6.9

%

Acetyl Chain

250

19.8

%

1,102

22.6

%

262

22.2

%

272

22.3

%

292

23.7

%

276

22.1

%

Other Activities(1)

(133

)

(505

)

(127

)

(121

)

(118

)

(139

)

Total

207

7.9

%

1,683

15.4

%

256

10.0

%

844

31.0

%

334

11.9

%

249

8.7

%

Equity Earnings and Dividend Income, Other Income (Expense) Attributable to Celanese Corporation

Engineered Materials

50

87

45

12

20

10

Acetyl Chain

36

132

33

33

32

34

Other Activities(1)

15

34

28

1

6

(1

)

Total

101

253

106

46

58

43

Non-Operating Pension and Other Post-Retirement Employee Benefit (Expense) Income Attributable to Celanese Corporation

Engineered Materials

(1

)

(1

)

Acetyl Chain

Other Activities(1)

2

(68

)

(66

)

(1

)

(2

)

1

Total

2

(69

)

(67

)

(1

)

(2

)

1

Certain Items Attributable to Celanese Corporation (Table 8)

Engineered Materials

61

(324

)

34

(476

)

25

93

Acetyl Chain

10

24

5

5

8

6

Other Activities(1)

26

186

100

33

21

32

Total

97

(114

)

139

(438

)

54

131

Adjusted EBIT / Adjusted EBIT Margin

Engineered Materials

201

14.6

%

848

13.8

%

199

14.2

%

229

15.0

%

205

12.9

%

215

13.2

%

Acetyl Chain

296

23.5

%

1,258

25.8

%

300

25.4

%

310

25.4

%

332

26.9

%

316

25.3

%

Other Activities(1)

(90

)

(353

)

(65

)

(88

)

(93

)

(107

)

Total

407

15.6

%

1,753

16.0

%

434

16.9

%

451

16.6

%

444

15.9

%

424

14.9

%

___________________________

(1)

Other Activities includes corporate SG&A expenses, results of captive insurance companies and certain components of net periodic benefit cost (interest cost, expected return on plan assets and net actuarial gains and losses).

Table 2 - Supplemental Segment Data and Reconciliation of Segment Adjusted EBIT and Operating EBITDA - Non-GAAP Measures - Unaudited (cont.)

Q1 '24

2023

Q4 '23

Q3 '23

Q2 '23

Q1 '23

(In $ millions, except percentages)

Depreciation and Amortization Expense(1)

Engineered Materials

102

447

112

111

112

112

Acetyl Chain

57

217

54

55

54

54

Other Activities(2)

17

27

8

7

6

6

Total

176

691

174

173

172

172

Operating EBITDA / Operating EBITDA Margin

Engineered Materials

303

22.0

%

1,295

21.1

%

311

22.1

%

340

22.3

%

317

20.0

%

327

20.1

%

Acetyl Chain

353

28.0

%

1,475

30.2

%

354

30.0

%

365

29.9

%

386

31.3

%

370

29.6

%

Other Activities(2)

(73

)

(326

)

(57

)

(81

)

(87

)

(101

)

Total

583

22.3

%

2,444

22.3

%

608

23.7

%

624

22.9

%

616

22.0

%

596

20.9

%

___________________________

(1)

Excludes accelerated depreciation and amortization expense, which amounts are included in Certain Items above. See Table 1 for details.

(2)

Other Activities includes corporate SG&A expenses, results of captive insurance companies and certain components of net periodic benefit cost (interest cost, expected return on plan assets and net actuarial gains and losses).

Table 3

Adjusted Earnings (Loss) per Share - Reconciliation of a Non-GAAP Measure - Unaudited

Q1 '24

2023

Q4 '23

Q3 '23

Q2 '23

Q1 '23

per
share

per
share

per
share

per
share

per
share

per
share

(In $ millions, except per share data)

Earnings (loss) from continuing operations attributable to Celanese Corporation

121

1.10

1,969

18.00

704

6.43

952

8.70

219

2.00

94

0.86

Income tax provision (benefit)

33

(790

)

(575

)

(236

)

(4

)

25

Earnings (loss) from continuing operations before tax

154

1,179

129

716

215

119

Certain Items attributable to Celanese Corporation (Table 8)

97

(114

)

139

(438

)

54

131

Refinancing and related expenses

7

7

Adjusted earnings (loss) from continuing operations before tax

251

1,072

268

285

269

250

Income tax (provision) benefit on adjusted earnings(1)

(23

)

(96

)

(23

)

(11

)

(32

)

(30

)

Adjusted earnings (loss) from continuing operations(2)

228

2.08

976

8.92

245

2.24

274

2.50

237

2.17

220

2.01

Diluted shares (in millions)(3)

Weighted average shares outstanding

109.1

108.8

109.0

108.9

108.9

108.6

Incremental shares attributable to equity awards

0.4

0.6

0.5

0.5

0.4

0.6

Total diluted shares

109.5

109.4

109.5

109.4

109.3

109.2

______________________________

(1)

Calculated using adjusted effective tax rates (Table 3a) as follows:

Q1 '24

2023

Q4 '23

Q3 '23

Q2 '23

Q1 '23

Adjusted effective tax rate

9

9

9

4

12

12

(2)

Excludes the immediate recognition of actuarial gains and losses and the impact of actual vs. expected plan asset returns.

Actual Plan
Asset Returns

Expected Plan
Asset Returns

(In percentages)

2023

8.1

5.2

(3)

Potentially dilutive shares are included in the adjusted earnings per share calculation when adjusted earnings are positive.

Table 3a

Adjusted Tax Rate - Reconciliation of a Non-GAAP Measure - Unaudited

Estimated

Actual

2024

2023

(In percentages)

US GAAP annual effective tax rate

22

(67

)

Discrete quarterly recognition of GAAP items(1)

2

Tax impact of other charges and adjustments(2)

(1

)

(3

)

Changes in valuation allowances, excluding impact of other charges and adjustments(3)

(6

)

13

Other, includes effect of discrete current year transactions(4)

(6

)

64

(5)

Adjusted tax rate

9

9

______________________________
Note: As part of the year-end reconciliation, we will update the reconciliation of the GAAP effective tax rate for actual results.

(1)

Such as changes in tax laws (including US tax reform), deferred taxes on outside basis differences, changes in uncertain tax positions and prior year audit adjustments.

(2)

Reflects the tax impact on pre-tax adjustments presented in Certain Items (Table 8), which are excluded from pre-tax income for adjusted earnings per share purposes.

(3)

Reflects changes in valuation allowances related to changes in judgment regarding the realizability of deferred tax assets or current year operations, excluding other charges and adjustments.

(4)

Includes tax impacts related to full-year actual tax opportunities and related costs, as well as current year realization of U.S. GAAP benefits deferred in prior years.

(5)

Includes the reversal of certain U.S. GAAP deferred tax benefits related to non-recurring internal restructuring transactions related to the M&M acquisition, to centralize ownership of intellectual property with the business and to facilitate future deployment of cash to service acquisition indebtedness. Certain benefits of the internal restructuring will be realized in future periods for adjusted earnings purposes.

Table 4

Net Sales by Segment - Unaudited

Q1 '24

2023

Q4 '23

Q3 '23

Q2 '23

Q1 '23

(In $ millions)

Engineered Materials

1,378

6,149

1,406

1,528

1,585

1,630

Acetyl Chain

1,261

4,884

1,181

1,220

1,233

1,250

Intersegment eliminations(1)

(28

)

(93

)

(18

)

(25

)

(23

)

(27

)

Net sales

2,611

10,940

2,569

2,723

2,795

2,853

___________________________

(1)

Includes intersegment sales primarily related to the Acetyl Chain.

Table 4a

Factors Affecting Segment Net Sales Sequentially - Unaudited

Three Months Ended March 31, 2024 Compared to Three Months Ended December 31, 2023

Volume

Price

Currency

Total

(In percentages)

Engineered Materials

(1

)

(1

)

(2

)

Acetyl Chain

5

1

1

7

Total Company

2

2

Three Months Ended December 31, 2023 Compared to Three Months Ended September 30, 2023

Volume

Price

Currency

Total

(In percentages)

Engineered Materials

(5

)

(3

)

(8

)

Acetyl Chain

(3

)

(3

)

Total Company

(3

)

(3

)

(6

)

Three Months Ended September 30, 2023 Compared to Three Months Ended June 30, 2023

Volume

Price

Currency

Total

(In percentages)

Engineered Materials

(1

)

(3

)

(4

)

Acetyl Chain

3

(3

)

(1

)

(1

)

Total Company

1

(3

)

(1

)

(3

)

Three Months Ended June 30, 2023 Compared to Three Months Ended March 31, 2023

Volume

Price

Currency

Total

(In percentages)

Engineered Materials

2

(5

)

(3

)

Acetyl Chain

2

(3

)

(1

)

Total Company

2

(4

)

(2

)

Three Months Ended March 31, 2023 Compared to Three Months Ended December 31, 2022

Volume

Price

Currency

Total

(In percentages)

Engineered Materials

34

(4

)

2

32

Acetyl Chain

10

(2

)

2

10

Total Company

19

(4

)

2

17

Table 4b

Factors Affecting Segment Net Sales Year Over Year - Unaudited

Three Months Ended March 31, 2024 Compared to Three Months Ended March 31, 2023

Volume

Price

Currency

Total

(In percentages)

Engineered Materials

(12

)

(2

)

(1

)

(15

)

Acetyl Chain

11

(10

)

1

Total Company

(2

)

(5

)

(1

)

(8

)

Three Months Ended December 31, 2023 Compared to Three Months Ended December 31, 2022

Volume

Price

Currency

Total

(In percentages)

Engineered Materials

21

(8

)

1

14

Acetyl Chain

14

(11

)

1

4

Total Company

18

(10

)

1

9

Three Months Ended September 30, 2023 Compared to Three Months Ended September 30, 2022

Volume

Price

Currency

Total

(In percentages)

Engineered Materials

75

(12

)

1

64

Acetyl Chain

4

(18

)

1

(13

)

Total Company

33

(16

)

1

18

Three Months Ended June 30, 2023 Compared to Three Months Ended June 30, 2022

Volume

Price

Currency

Total

(In percentages)

Engineered Materials

75

(8

)

67

Acetyl Chain

(2

)

(19

)

(21

)

Total Company

27

(15

)

12

Three Months Ended March 31, 2023 Compared to Three Months Ended March 31, 2022

Volume

Price

Currency

Total

(In percentages)

Engineered Materials

80

2

(3

)

79

Acetyl Chain

(9

)

(13

)

(2

)

(24

)

Total Company

23

(8

)

(3

)

12

Table 4c

Factors Affecting Segment Net Sales Year Over Year - Unaudited

Year Ended December 31, 2023 Compared to Year Ended December 31, 2022

Volume

Price

Currency

Total

(In percentages)

Engineered Materials

54

(1

)

53

Acetyl Chain

2

(17

)

(15

)

Total Company

23

(10

)

13

Table 5

Free Cash Flow - Reconciliation of a Non-GAAP Measure - Unaudited

Q1 '24

2023

Q4 '23

Q3 '23

Q2 '23

Q1 '23

(In $ millions, except percentages)

Net cash provided by (used in) investing activities

(151

)

(134

)

(168

)

375

(163

)

(178

)

Net cash provided by (used in) financing activities

(259

)

(1,456

)

(240

)

(700

)

(447

)

(69

)

Net cash provided by (used in) operating activities

101

1,899

830

403

762

(96

)

Capital expenditures on property, plant and equipment

(137

)

(568

)

(128

)

(131

)

(145

)

(164

)

Contributions from/(Distributions) to NCI

(4

)

(11

)

(4

)

(6

)

(1

)

Free cash flow(1)

(40

)

1,320

702

268

611

(261

)

Net sales

2,611

10,940

2,569

2,723

2,795

2,853

Free cash flow as % of Net sales

(1.5

)%

12.1

%

27.3

%

9.8

%

21.9

%

(9.1

)%

______________________________

(1)

Free cash flow is a liquidity measure used by the Company and is defined by the Company as net cash provided by (used in) operating activities, less capital expenditures on property, plant and equipment, and adjusted for contributions from or distributions to our NCI joint ventures.

Table 6

Cash Dividends Received - Unaudited

Q1 '24

2023

Q4 '23

Q3 '23

Q2 '23

Q1 '23

(In $ millions)

Dividends from equity method investments

27

157

85

7

25

40

Dividends from equity investments without readily determinable fair values

34

126

31

30

31

34

Total

61

283

116

37

56

74

Table 7

Net Debt - Reconciliation of a Non-GAAP Measure - Unaudited

Q1 '24

2023

Q4 '23

Q3 '23

Q2 '23

Q1 '23

(In $ millions)

Short-term borrowings and current installments of long-term debt - third party and affiliates

2,439

1,383

1,383

1,408

1,507

1,386

Long-term debt, net of unamortized deferred financing costs

11,018

12,301

12,301

12,291

12,889

13,396

Total debt

13,457

13,684

13,684

13,699

14,396

14,782

Cash and cash equivalents

(1,483

)

(1,805

)

(1,805

)

(1,357

)

(1,296

)

(1,167

)

Net debt

11,974

11,879

11,879

12,342

13,100

13,615

Table 8

Certain Items - Unaudited

The following Certain Items attributable to Celanese Corporation are included in Net earnings (loss) and are adjustments to non-GAAP measures:

Q1 '24

2023

Q4 '23

Q3 '23

Q2 '23

Q1 '23

Income Statement Classification

(In $ millions)

Exit and shutdown costs

68

89

33

9

21

26

Cost of sales / SG&A / Other (charges) gains, net / Gain (loss) on disposition of businesses and assets, net / Non-operating pension and other postretirement employee benefit (expense) income

Asset impairments

15

6

9

Cost of sales / Other (charges) gains, net

Impact from plant incidents and natural disasters(1)

7

6

6

Cost of sales

Mergers, acquisitions and dispositions

25

195

27

46

23

99

Cost of sales / SG&A

Actuarial (gain) loss on pension and postretirement plans

69

69

Cost of sales / SG&A / Non-operating pension and other postretirement employee benefit (expense) income

Legal settlements and commercial disputes

(8

)

12

4

2

6

Cost of sales / SG&A / Other (charges) gains, net

(Gain) loss on disposition of businesses and assets

(510

)

(3

)

(508

)

1

Gain (loss) on disposition of businesses and assets, net

Other

5

10

3

4

3

Cost of sales / SG&A

Certain Items attributable to Celanese Corporation

97

(114

)

139

(438

)

54

131

___________________________

(1)

Primarily associated with Winter Storms Heather and Elliott in 2024 and 2023, respectively.

Table 9

Return on Invested Capital (Adjusted) - Presentation of a Non-GAAP Measure - Unaudited

2023

(In $ millions, except
percentages)

Net earnings (loss) attributable to Celanese Corporation

1,960

Adjusted EBIT (Table 1)

1,753

Adjusted effective tax rate (Table 3a)

9

%

Adjusted EBIT tax effected

1,595

2023

2022

Average

(In $ millions, except percentages)

Short-term borrowings and current installments of long-term debt - third parties and affiliates

1,383

1,306

1,345

Long-term debt, net of unamortized deferred financing costs

12,301

13,373

12,837

Celanese Corporation shareholders' equity

7,091

5,637

6,364

Invested capital

20,546

Return on invested capital (adjusted)

7.8

%

Net earnings (loss) attributable to Celanese Corporation as a percentage of invested capital

9.5

%

Investor Relations

Bill Cunningham

Phone: +1 484 905 1129

[email protected]

Media - U.S.

Brian Bianco

Phone: +1 972 443 4400

[email protected]

Media - Europe

Petra Czugler

Phone: +49 69 45009 1206

[email protected]

Source: Celanese Corporation

Categories

Business Wire Press Releases

Next Articles